MX9203768A - Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a. - Google Patents

Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a.

Info

Publication number
MX9203768A
MX9203768A MX9203768A MX9203768A MX9203768A MX 9203768 A MX9203768 A MX 9203768A MX 9203768 A MX9203768 A MX 9203768A MX 9203768 A MX9203768 A MX 9203768A MX 9203768 A MX9203768 A MX 9203768A
Authority
MX
Mexico
Prior art keywords
methylglutaril
coenzyme
reductase
hydroxy
novel inhibitors
Prior art date
Application number
MX9203768A
Other languages
English (en)
Inventor
Kent W Neuenschwander
John R Reagan
Benedict J Kosmider
Original Assignee
Rhone Poulenc Rorer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Int filed Critical Rhone Poulenc Rorer Int
Publication of MX9203768A publication Critical patent/MX9203768A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9203768A 1987-12-21 1992-06-29 Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a. MX9203768A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/135,805 US4863957A (en) 1987-12-21 1987-12-21 Novel HMG-CoA reductase inhibitors

Publications (1)

Publication Number Publication Date
MX9203768A true MX9203768A (es) 1992-07-01

Family

ID=22469757

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203768A MX9203768A (es) 1987-12-21 1992-06-29 Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a.

Country Status (6)

Country Link
US (1) US4863957A (es)
EP (1) EP0403487A4 (es)
JP (1) JPH03503280A (es)
AU (1) AU636102B2 (es)
MX (1) MX9203768A (es)
WO (1) WO1989005639A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904691A (en) * 1987-12-21 1990-02-27 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US4997658A (en) * 1988-11-21 1991-03-05 Merck & Co., Inc. Method for enhancing the lowering of plasma cholesterol levels
US5376383A (en) * 1988-11-21 1994-12-27 Merck & Co., Inc. Method for enhancing the lowering of plasma-cholesterol levels
DE3909378A1 (de) * 1989-03-22 1990-09-27 Bayer Ag Substituierte biphenyle
US5114964A (en) * 1989-11-03 1992-05-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl-substituted benzocycloalkyl-derived anti-atherosclerotic agents
WO1991013616A1 (en) * 1990-03-08 1991-09-19 Rorer International (Overseas) Inc. NOVEL HMG-CoA REDUCTASE INHIBITORS
US5216015A (en) * 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
US5258544A (en) * 1991-03-05 1993-11-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Synthesis of aldehydes useful in the preparations of HMG-CoA reductase inhibitors
KR950005791A (ko) * 1993-08-09 1995-03-20 후꾸야마 마사루 카르복실산 에스테르-유도체의 제조방법 및 그 방법에 사용되는 4- 플루오로비페닐 유도체
UA101556C2 (uk) 2006-07-05 2013-04-10 Нікомед Гмбх Комбіноване застосування інгібітора pde 4 та інгібітора hmg-coa-редуктази для профілактики або зцілювального лікування запального захворювання легенів
US9056850B2 (en) 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
PL2488515T3 (pl) 2009-10-14 2017-07-31 Janssen Pharmaceutica Nv Sposób wytwarzania związków użytecznych jako inhibitory sglt2
MY187718A (en) 2010-05-11 2021-10-14 Janssen Pharmaceutica Nv Pharmaceutical formulations
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
WO2012140120A1 (en) 2011-04-13 2012-10-18 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
WO2012170417A2 (en) 2011-06-06 2012-12-13 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin
BR112019015107A2 (pt) 2017-01-23 2020-03-10 Dong Wha Pharm. Co., Ltd. Formulação de complexo compreendendo inibidor de hmg-coa redutase e clopidogrel
US20210008084A1 (en) 2017-10-16 2021-01-14 Tsinghua University Mevalonate pathway inhibitor and pharmaceutical composition thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
US4308378A (en) * 1980-09-02 1981-12-29 Merck & Co., Inc. Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones
US4503072A (en) * 1982-12-22 1985-03-05 Merck & Co., Inc. Antihypercholesterolemic compounds
US4622338A (en) * 1985-03-11 1986-11-11 G. D. Searle & Co. Substituted glutaric acid lactones in the treatment of hyperlipidemia
EP0217092B1 (de) * 1985-08-29 1990-03-28 Hoechst Aktiengesellschaft 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte
US4772626A (en) * 1986-01-31 1988-09-20 Merck & Co., Inc. Antihypercholesterolemic compounds

Also Published As

Publication number Publication date
US4863957A (en) 1989-09-05
JPH03503280A (ja) 1991-07-25
AU2925989A (en) 1989-07-19
WO1989005639A1 (en) 1989-06-29
EP0403487A1 (en) 1990-12-27
EP0403487A4 (en) 1991-06-05
AU636102B2 (en) 1993-04-22

Similar Documents

Publication Publication Date Title
FI882384A (fi) Fosforhaltiga hmg-coa -reduktasinhibitorer och deras framstaellningsfoerfarande.
DE3681991D1 (de) Hmg-coa-reduktase-hemmungskoerper.
DK317287D0 (da) Reduktase-inhibitorer
DE3864608D1 (de) Hmg-coa-reduktasehemmer.
MX9203768A (es) Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a.
DK226888A (da) Steroid 5-alfa-reduktase inhibitor
DE3881826T2 (de) Formbare Kontaktklebstoffe.
NO884925L (no) Renininhibitorer.
DE3879742D1 (de) Klebstoffe.
FI904101A0 (fi) 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer.
DE68904083T2 (de) Hmg-coa-reduktaseinhibitoren.
DE68901091D1 (de) Hmg-coa-reduktaseinhibitoren.
DE3872182T2 (de) Korrosionsinhibitor.
DE3881373D1 (de) Hmg-coa-reduktase-hemmer.
ATE119535T1 (de) Acetylcholinesterase-inhibitoren.
ZA886468B (en) Novel hmg-coa reductase inhibitors
DE68900988D1 (de) Hmg-coa-reduktase-inhibitoren.
FR2654822B1 (fr) Dispenseur de sous-projectiles.
DE3869282D1 (de) Inhibitoren von hmg-coa-reduktase.
IT8819608A0 (it) Procedimento per la carbocementazione di un pezzo di acciaio.
NO872985L (no) Inhibitor for polyuretanpropergoler.
ZA874487B (en) Novel hmg-coa reductase inhibitors
DE3872187T2 (de) Uhrwerk.
FR2624987B3 (fr) Montre-bracelet
FR2611522B1 (fr) Jeu de quilles